In breast cancer, FGF2 mRNA expression positively correlates with CAF abundance, and siRNA silencing of FGFR1 in MDA-MB-231 breast cancer cells co-implanted with FGF2+ CAFs significantly reduced xenograft tumor burden [304]. Here, FGFR1 is linked to breast carcinoma.